BioPort seeks anthrax facility certification

BioPort (Lansing, Mich.) filed an application with FDA for certification of its renovated anthrax vaccine manufacturing facility, HHS Secretary Tommy Thompson said on Tuesday. Speaking at a House hearing, Thompson added that FDA will inspect the facility soon and if it meets the agency's standards, the facility "should be operational by the 22nd of November." He said "there has been an ongoing conflict between FDA and Bioport for some time, and that conflict has been brought on mainly by Bioport for not performing a good manufacturing system. They are improving that and modernizing and cleaning their plant, and now we'll go in and it will be inspected by FDA." ...